About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our research group is accredited by the Agency for Management of University and Research Grants (AGAUR) in Catalonia, and focuses on two main areas of interest which are related to Solid Organ Transplantation and especially Kidney, and in clinical Nephrology. We tackle these areas from an innovative perspective, both basic-experimental and mechanistic, always with a translational goal. On the one hand, we investigate, develop, and use novel diagnostic and therapeutic technologies to decipher and target main molecular and immune mechanisms of transplant rejection as well as the immune susceptibility to opportunistic infections and malignancies. Also, a main task force of the group is devoted to better understand the main mechanisms involved in certain autoimmune glomerular diseases and idiopathic nephrotic syndrome as well as in diabetic kidney disease, having a specific interest in the role of the renin-angiotensin system. Our ultimate goal is to improve the management and care of patients suffering from kidney diseases as well as their quality of life, reducing associated morbidity and mortality.
PMID: 35669972 Journal: TRANSPLANT INTERNATIONAL Year: 2022 Reference: Transpl Int. 2022 May 20;35:10138. doi: 10.3389/ti.2022.10138. eCollection 2022. Impact factor: 3.782 Publication type: Editorail in international publication Authors: Oberbauer, Rainer, Pengel, Liset, Schneeberger, Stefan, Naesens, Maarten, Mamode, Nizam, Heemann, Uwe, Furian, Lucrezia, Couzi, Lionel, Claas, Frans, Budde, Klemens et al. DOI: 10.3389/ti.2022.10138
PMID: 35669978 Journal: TRANSPLANT INTERNATIONAL Year: 2022 Reference: Transpl Int. 2022 May 20;35:10141. doi: 10.3389/ti.2022.10141. eCollection 2022. Impact factor: 3.782 Publication type: Editorail in international publication Authors: Rabant, Marion, Roufosse, Candice, Naesens, Maarten, Seron, Daniel, Becker, Jan Ulrich et al. DOI: 10.3389/ti.2022.10141
PMID: 35669975 Journal: TRANSPLANT INTERNATIONAL Year: 2022 Reference: Transpl Int. 2022 May 20;35:10135. doi: 10.3389/ti.2022.10135. eCollection 2022. Impact factor: 3.782 Publication type: Review in international publication Authors: Bellini, Maria Irene, Seron, Daniel, Rabant, Marion, Becker, Jan Ulrich, Roufosse, Candice, Diekmann, Fritz, Glotz, Denis, Hilbrands, Luuk, Loupy, Alexandre, Oberbauer, Rainer et al. DOI: 10.3389/ti.2022.10135
PMID: 35664277 Journal: Clinical Kidney Journal Year: 2022 Reference: Clin Kidney J. 2022 May 30;15(6):1029-1033. doi: 10.1093/ckj/sfac121. eCollection 2022 Jun. Impact factor: 4.452 Publication type: Editorail in international publication Authors: Soler, Maria Jose et al. DOI: 10.1093/ckj/sfac121
PMID: 34174006 Journal: Transplant Infectious Disease Year: 2021 Reference: Transpl Infect Dis. 2021 Aug;23(4):e13677. doi: 10.1111/tid.13677. Epub 2021 Jul 12. Impact factor: 2.228 Publication type: Letter or abstract Authors: Garcia-Garcia, Sonia, Los-Arcos, Ibai, Moreso, Francesc, Berastegui, Cristina, Castells, Lluis, Gorgas Torner, Maria Q, Miarons, Marta, Larrosa-Garcia, Maria et al. DOI: 10.1111/tid.13677
PMID: 33359528 Journal: KIDNEY INTERNATIONAL Year: 2021 Reference: Kidney Int. 2021 Jul;100(1):196-205. doi: 10.1016/j.kint.2020.12.015. Epub 2020 Dec 24. Impact factor: 10.612 Publication type: Paper in international publication Authors: Blosser, Christopher, Zuniga, Sandra Carias, Soler, Maria Jose, Moreso, Francesc, Mithani, Zain, Ortiz-Melo, David, Jaimes, Edgar A, Gutgarts, Victoria, Lum, Erik, Danovitch, Gabriel M et al. DOI: 10.1016/j.kint.2020.12.015
PMID: 34088718 Journal: Clinical Journal of the American Society of Nephrology Year: 2021 Reference: Clin J Am Soc Nephrol. 2021 Jul;16(7):1061-1072. doi: 10.2215/CJN.18961220. Epub 2021 Jun 4. Impact factor: 8.237 Publication type: Paper in international publication Authors: Soler, Maria Jose, Noordzij, Marlies, Abramowicz, Daniel, de Arriba, Gabriel, Basile, Carlo, van Buren, Marjolijn, Covic, Adrian, Crespo, Marta, Duivenvoorden, Raphael, Massy, Ziad et al. DOI: 10.2215/CJN.18961220
PMID: 34098555 Journal: KIDNEY & BLOOD PRESSURE RESEARCH Year: 2021 Reference: Kidney Blood Press Res. 2021;46(4):452-459. doi: 10.1159/000515714. Epub 2021 Jun 7. Impact factor: 2.687 Publication type: Paper in international publication Authors: Agraz, Irene, Roman, Juan Leon, Garcia-Carro, Clara, Gabaldon, Alejandra, Torres, Irina, Bury, Roxana, Baldallo, Cinthia, Seron, Daniel, Soler, Maria Jose, Vergara, Ander et al. DOI: 10.1159/000515714
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
Hypertension, a key risk factor for heart disease that contributes significantly to cardiovascular mortality and morbidity and damage to vital organs, was the focus of this multi-centre study.
The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.
